Mode
Text Size
Log in / Sign up

Postmortem tryptase concentration shows high diagnostic accuracy for identifying fatal anaphylaxis in forensic casesPostmortem Tryptase Levels Help Identify Fatal Anaphylaxis Cases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that postmortem tryptase is a high-performing marker for identifying fatal anaphylaxis in forensic investigations.

This meta-analysis evaluates the diagnostic performance of postmortem serum tryptase as a marker for fatal anaphylaxis. The analysis included 105 anaphylactic deaths and 449 non-anaphylactic controls. The study found a marked increase in postmortem tryptase concentrations in anaphylactic deaths, with a ratio of means of 8.68 (95% CI 2.12-35.57).

Regarding diagnostic performance, the analysis reported a sensitivity of 0.80, a specificity of 0.92, and an area under the receiver operating characteristic curve (AUC) of 0.94. These findings suggest that tryptase is a robust marker for identifying anaphylaxis in forensic investigations. However, the authors note that reported cut-off values are descriptive rather than indicative of a universal threshold.

Limitations noted by the authors include a lack of methodological standardization and heterogeneity in study design and methodology. Clinically, postmortem tryptase is strongly associated with fatal anaphylaxis and serves as a valuable additional marker in forensic investigations. However, results must be interpreted alongside clinical, circumstantial, and autopsy findings to confirm a diagnosis.

How this fits prior evidence

This meta-analysis addresses a gap in forensic investigation by providing objective markers for fatal anaphylaxis. It complements existing evidence regarding multimodal diagnostic strategies for Hymenoptera venom allergy and mast-cell disorders by offering a postmortem diagnostic tool. While previous evidence focused on clinical management and triggers, this finding provides a specific biochemical marker for forensic confirmation of anaphylaxis.

Researchers analyzed data from 105 cases of fatal anaphylaxis and 449 other deaths to see if tryptase levels could help identify allergic reactions. Tryptase is a substance released by certain cells during an allergic response. The study found that these levels were significantly higher in people who died from anaphylaxis compared to those who did not.

The analysis showed that testing for tryptase has good accuracy for identifying these cases. It had a sensitivity of 0.80 and a specificity of 0.92. This means the test is a helpful tool for forensic experts trying to determine the cause of death when a patient's condition is unclear.

Because the study looked at postmortem cases, these results are meant for forensic investigation rather than immediate clinical use. There were some differences in how different studies were designed, which can affect how results are applied. Doctors and forensic experts should use these results alongside other clinical evidence and autopsy findings to reach a final conclusion.

What this means for you:
Higher tryptase levels in blood after death are strongly linked to fatal anaphylaxis cases.

Common questions

What is tryptase and how is it used?

Tryptase is a substance released during an allergic reaction. In this study, it was measured in blood samples after death. The results showed that tryptase levels were significantly higher in cases of fatal anaphylaxis. This makes it a valuable marker for forensic experts to help determine if a person died from a severe allergic reaction.

How accurate is the tryptase test for identifying anaphylaxis?

The study found that testing for tryptase has good overall performance. It showed a sensitivity of 0.80 and a specificity of 0.92. These numbers indicate that the test is a reliable way to help identify anaphylaxis, though it should be used alongside other clinical and autopsy findings.

Can this test be used to treat patients immediately?

No, this specific study looked at postmortem cases, which means it was conducted after death. The findings are intended to help forensic experts identify the cause of death in a laboratory setting. It is not a tool for immediate medical treatment or diagnosis for living patients.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Fatal anaphylaxis remains a diagnostically challenging condition in forensic practice, particularly in the postmortem setting where clinical information is often limited. Postmortem serum tryptase has been widely proposed as a marker of mast cell activation, but its quantitative significance and diagnostic performance have not been consistently defined. This systematic review and meta-analysis aimed to evaluate both the magnitude of tryptase elevation and its diagnostic accuracy in fatal anaphylaxis. Seven studies were included, comprising 105 anaphylactic deaths and 449 non-anaphylactic controls. Continuous meta-analysis demonstrated a marked increase in postmortem tryptase concentrations in anaphylactic deaths, with a pooled ratio of means of 8.68 (95% confidence interval 2.12-35.57). Diagnostic meta-analysis showed good overall performance, with pooled sensitivity of 0.80 and specificity of 0.92, and an area under the receiver operating characteristic curve of 0.94. These findings were consistent across sensitivity analyses despite substantial heterogeneity in study design and methodology. Although reported diagnostic cut-off values varied widely, most studies using standardized methods and femoral blood sampling showed clustering of thresholds within a relatively narrow range. However, this pattern should be interpreted as descriptive rather than indicative of a universal threshold. Postmortem tryptase is strongly associated with fatal anaphylaxis and represents a valuable additional marker in forensic investigations. Its interpretation, however, must be integrated with clinical, circumstantial, and autopsy findings. The lack of methodological standardization remains a major limitation, and future studies adopting harmonized protocols are needed to improve diagnostic reliability.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.